Zachary Isaac Merhavy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zachary Isaac Merhavy has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Chandy Varkey
Department of Neurology, University of Arizona College of Medicine, Phoenix, AZ 85004, USA
9 shared publications - Jack B. Ding
Adelaide Medical School, The University of Adelaide, Adelaide, Australia
3 shared publications - John A. Varkey
College of Engineering, The University of Notre Dame, Notre Dame, Indiana, USA
3 shared publications - Colton M Zeitler
Midwestern University, Arizona College of Osteopathic Medicine, Glendale, Arizona, AZ85308, United States
2 shared publications - Eliu Rivera
University of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis
2 shared publications Imran Siddiqi
University of Maryland
2 shared publications
Latest Publications
- Open Access
- 21 February 2026
- Published by Springer Nature in Perioperative Medicine
- Vol. 15 (1)
Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially developed for the management of type 2 diabetes, due to their role in enhancing insuli
- 21 February 2026
- Published by Springer Nature in Perioperative Medicine
- Vol. 15 (1)
Open AccessPerioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially developed for the management of type 2 diabetes, due to their role in enhancing insuli
- Open Access
- 9 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14 (4)
Sedation and analgesia strategies in the neuro intensive care unit
Intensivists are often plagued with the challenges of managing critically ill patients in the neurocritical intensive care unit (neuro ICU); one such challenge is the level of illness and the need for sedation, inhibiting the provider’s ability to adequately assess the patient. Most sedatives alter neurological and physical exam findings, only compounding potential barriers to providing the best care for each patient. It is important to emphasize that even in the altered mentation of these patients, physical and neurological exams reign supreme as diagnostic tools and should be used in conjunction with multimodal neuromonitoring methods, rather than labs or imaging alone. Additionally, selecting the appropriate analgesic(s) and sedative(s) based on these findings are highly important when determining the best course of individualized management. Thus, providers in the neuro ICU should be highly familiar with the appropriate analgesic and sedative options available in order to determine not only which may be best for each patient, but to also better understand how each drug may impact assessment findings. This comprehensive review aims to provide a structured overview of the pertinent sedatives commonly used in neuro ICUs, their risks and benefits, and how providers can best utilize each in practice to further improve patient outcomes. The novel contribution of this work provides comparative drug tables, dosing guidance for pediatric and very elderly (> 85-years-old) populations, and an exploration into the future possibilities of utilizing artificial intelligence and the human gut microbiome to further enhance the prospects of precision medicine.
- 9 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14 (4)
Open AccessSedation and analgesia strategies in the neuro intensive care unit
Intensivists are often plagued with the challenges of managing critically ill patients in the neurocritical intensive care unit (neuro ICU); one such challenge is the level of illness and the need for sedation, inhibiting the provider’s ability to adequately assess the patient. Most sedatives alter neurological and physical exam findings, only compounding potential barriers to providing the best care for each patient. It is important to emphasize that even in the altered mentation of these patients, physical and neurological exams reign supreme as diagnostic tools and should be used in conjunction with multimodal neuromonitoring methods, rather than labs or imaging alone. Additionally, selecting the appropriate analgesic(s) and sedative(s) based on these findings are highly important when determining the best course of individualized management. Thus, providers in the neuro ICU should be highly familiar with the appropriate analgesic and sedative options available in order to determine not only which may be best for each patient, but to also better understand how each drug may impact assessment findings. This comprehensive review aims to provide a structured overview of the pertinent sedatives commonly used in neuro ICUs, their risks and benefits, and how providers can best utilize each in practice to further improve patient outcomes. The novel contribution of this work provides comparative drug tables, dosing guidance for pediatric and very elderly (> 85-years-old) populations, and an exploration into the future possibilities of utilizing artificial intelligence and the human gut microbiome to further enhance the prospects of precision medicine.
- 3 July 2025
- Published by Elsevier in Ethics, Medicine and Public Health
- Vol. 33
Caring beyond their years: The global landscape of young carers and their needs
- 3 July 2025
- Published by Elsevier in Ethics, Medicine and Public Health
- Vol. 33
Caring beyond their years: The global landscape of young carers and their needs
- Open Access
- 20 November 2024
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 45 (6) , 305-316
Long COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems
Long coronavirus disease (COVID), also known as the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), is a significant concern since the end of the COVID-19 pandemic, as it still manifests in individuals with persistent symptoms and complications beyond the acute phase of infection. Defining this disease is challenging, as it manifests as a spectrum of symptoms varying in severity among individuals who have previously tested positive for COVID-19. Long COVID is more prevalent in hospitalized COVID-19 patients and presents in various ways, ranging from pulmonary to extrapulmonary symptoms. This literature review examines the current body of research on long COVID with a focus on its effects on the cardiovascular, hematological, respiratory, renal, and neurological systems with systematically analyzed, peer-reviewed articles retrieved from the PubMed database. There have been several proposed pathophysiological mechanisms by which severe acute respiratory syndrome coronavirus 2 affects the aforementioned organ systems; however, research on the definite mechanisms is lacking, especially when considering the management of long COVID in the perioperative setting. The impact of post-COVID sequelae necessitates individualized management strategies tailored to each symptomatic profile, particularly in patients with comorbidities. The COVID-19 pandemic affected millions of people and had a profound impact on those who developed PASC, lowering their quality of life and increasing potential surgical risks. However, there is still uncertainty regarding the specific risk factors for long COVID and who is most susceptible to it. Further research is required to fill these gaps and explore potential avenues for preventing PASC.
- 20 November 2024
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 45 (6) , 305-316
Open AccessLong COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems
Long coronavirus disease (COVID), also known as the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), is a significant concern since the end of the COVID-19 pandemic, as it still manifests in individuals with persistent symptoms and complications beyond the acute phase of infection. Defining this disease is challenging, as it manifests as a spectrum of symptoms varying in severity among individuals who have previously tested positive for COVID-19. Long COVID is more prevalent in hospitalized COVID-19 patients and presents in various ways, ranging from pulmonary to extrapulmonary symptoms. This literature review examines the current body of research on long COVID with a focus on its effects on the cardiovascular, hematological, respiratory, renal, and neurological systems with systematically analyzed, peer-reviewed articles retrieved from the PubMed database. There have been several proposed pathophysiological mechanisms by which severe acute respiratory syndrome coronavirus 2 affects the aforementioned organ systems; however, research on the definite mechanisms is lacking, especially when considering the management of long COVID in the perioperative setting. The impact of post-COVID sequelae necessitates individualized management strategies tailored to each symptomatic profile, particularly in patients with comorbidities. The COVID-19 pandemic affected millions of people and had a profound impact on those who developed PASC, lowering their quality of life and increasing potential surgical risks. However, there is still uncertainty regarding the specific risk factors for long COVID and who is most susceptible to it. Further research is required to fill these gaps and explore potential avenues for preventing PASC.
- Open Access
- 29 October 2024
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 16 (4) , 279-285
Navigating Buprenorphine Therapy: A Closer Look at Microdosing vs. Macrodosing for Pain Management and Opioid Addiction – A Narrative Review
Background: Buprenorphine therapy has emerged as a primary therapy method for both opioid addiction and chronic pain; however, the «one size fits all» approach to buprenorphine administration is no longer tenable. This review analyzes the pharmacology of both dosing approaches and their clinical outcomes, safety profiles, and societal implications, providing valuable insights for healthcare professionals. Methods: Multiple databases were used in conjunction with a set of inclusion and exclusion criteria to source articles to assess the consensus of best methods for treating opioid use disorder (OUD). This comprehensive review discusses two distinct dosing strategies, microdosing and macrodosing, through a detailed literature search to assess the differences and similarities of each strategy. Findings: Microdosing entails administering minimal buprenorphine doses, with promise in pain alleviation and addiction management while mitigating the risks of dependence and side effects typically associated with traditional opioids. In contrast, macrodosing employs higher buprenorphine doses, which is well-established for OUD and chronic pain management but raises concerns concerning misuse and overdose. Conclusion: Tailoring buprenorphine therapy to patients’ individual needs is essential in the face of contemporary healthcare challenges related to pain management and opioid addiction.
- 29 October 2024
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 16 (4) , 279-285
Open AccessNavigating Buprenorphine Therapy: A Closer Look at Microdosing vs. Macrodosing for Pain Management and Opioid Addiction – A Narrative Review
Background: Buprenorphine therapy has emerged as a primary therapy method for both opioid addiction and chronic pain; however, the «one size fits all» approach to buprenorphine administration is no longer tenable. This review analyzes the pharmacology of both dosing approaches and their clinical outcomes, safety profiles, and societal implications, providing valuable insights for healthcare professionals. Methods: Multiple databases were used in conjunction with a set of inclusion and exclusion criteria to source articles to assess the consensus of best methods for treating opioid use disorder (OUD). This comprehensive review discusses two distinct dosing strategies, microdosing and macrodosing, through a detailed literature search to assess the differences and similarities of each strategy. Findings: Microdosing entails administering minimal buprenorphine doses, with promise in pain alleviation and addiction management while mitigating the risks of dependence and side effects typically associated with traditional opioids. In contrast, macrodosing employs higher buprenorphine doses, which is well-established for OUD and chronic pain management but raises concerns concerning misuse and overdose. Conclusion: Tailoring buprenorphine therapy to patients’ individual needs is essential in the face of contemporary healthcare challenges related to pain management and opioid addiction.
- Open Access
- 15 September 2024
- Published by Springer Nature in BMC Medical Education
- Vol. 24 (1) , 1-3
Can criticism lead to constructive dialogue? Reaffirming a novel study
This letter takes a unique approach to the complex relationship between criticism and constructive dialogue, specifically in response to issues raised by a recent original article publication. While criticism is often viewed negatively, this article uncovers its potential to stimulate meaningful and productive discussions, particularly in novel studies. By examining certain misinterpretations, the article aims to demonstrate how criticism, when approached with openness and respect, can deepen the understanding and appreciation of original works, and inspire future research on lecture playback speeds. Drawing from specific matters arising based on one writer’s Letter to the Editor, this response highlights the importance of cultivating a culture of constructive criticism in educational settings through a thorough response where criticism has led to fruitful dialogue, enabling readers to engage critically with texts and explore diverse interpretations. Ultimately, this article underscores the transformative potential of criticism as a tool for intellectual growth, by reaffirming the value of novel studies as sites for critical inquiry and potential constructive dialogue rather than a deterrent to meaningful engagement. It endeavors to provide practical insights and recommendations for writers, offering strategies for leveraging criticism to foster deeper collaboration and enrich future scholarly works.
- 15 September 2024
- Published by Springer Nature in BMC Medical Education
- Vol. 24 (1) , 1-3
Open AccessCan criticism lead to constructive dialogue? Reaffirming a novel study
This letter takes a unique approach to the complex relationship between criticism and constructive dialogue, specifically in response to issues raised by a recent original article publication. While criticism is often viewed negatively, this article uncovers its potential to stimulate meaningful and productive discussions, particularly in novel studies. By examining certain misinterpretations, the article aims to demonstrate how criticism, when approached with openness and respect, can deepen the understanding and appreciation of original works, and inspire future research on lecture playback speeds. Drawing from specific matters arising based on one writer’s Letter to the Editor, this response highlights the importance of cultivating a culture of constructive criticism in educational settings through a thorough response where criticism has led to fruitful dialogue, enabling readers to engage critically with texts and explore diverse interpretations. Ultimately, this article underscores the transformative potential of criticism as a tool for intellectual growth, by reaffirming the value of novel studies as sites for critical inquiry and potential constructive dialogue rather than a deterrent to meaningful engagement. It endeavors to provide practical insights and recommendations for writers, offering strategies for leveraging criticism to foster deeper collaboration and enrich future scholarly works.
- Open Access
- 22 August 2024
- Published by European Medical Group in EMJ Diabetes
- p. 72-75
A Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action
Presented here is a case of Mauriac syndrome with persistent lactatemia in a 21-year-old female with a history of poor glycaemic control. Mauriac syndrome is a severe complication of Type 1 diabetes mellitus (T1DM) characterised by glycogen accumulation in the liver leading to hepatomegaly. Mauriac syndrome is considered to be a very rare and preventable complication due to better treatment options for T1DM. Most cases of Mauriac syndrome today involve children and adolescents who face socioeconomic inequities that prevent them from accessing adequate healthcare and affording insulin, as is the case with this patient. The combination of low health literacy, insulin unaffordability, and difficulty accessing healthcare for her chronic condition all contributed to her poorly controlled T1DM. It has been well established that insulin has become difficult to afford for insulin-dependent patients. An alarming one out of four insulin-dependent patients have rationed their doses due to the high cost of insulin. Progress has been made to cap the price of insulin at 35 USD to prevent price-gouging for certain populations in the USA but not all. Young patients with poorly controlled T1DM and low socioeconomic status require higher levels of social support and public health intervention to prevent serious complications of T1DM such as Mauriac syndrome.
- 22 August 2024
- Published by European Medical Group in EMJ Diabetes
- p. 72-75
Open AccessA Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action
Presented here is a case of Mauriac syndrome with persistent lactatemia in a 21-year-old female with a history of poor glycaemic control. Mauriac syndrome is a severe complication of Type 1 diabetes mellitus (T1DM) characterised by glycogen accumulation in the liver leading to hepatomegaly. Mauriac syndrome is considered to be a very rare and preventable complication due to better treatment options for T1DM. Most cases of Mauriac syndrome today involve children and adolescents who face socioeconomic inequities that prevent them from accessing adequate healthcare and affording insulin, as is the case with this patient. The combination of low health literacy, insulin unaffordability, and difficulty accessing healthcare for her chronic condition all contributed to her poorly controlled T1DM. It has been well established that insulin has become difficult to afford for insulin-dependent patients. An alarming one out of four insulin-dependent patients have rationed their doses due to the high cost of insulin. Progress has been made to cap the price of insulin at 35 USD to prevent price-gouging for certain populations in the USA but not all. Young patients with poorly controlled T1DM and low socioeconomic status require higher levels of social support and public health intervention to prevent serious complications of T1DM such as Mauriac syndrome.
- Open Access
- 22 August 2024
- Published by European Medical Group in EMJ Diabetes
- Vol. 12 (1)
A Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action
Presented here is a case of Mauriac syndrome with persistent lactatemia in a 21-year-old female with a history of poor glycaemic control. Mauriac syndrome is a severe complication of Type 1 diabetes mellitus (T1DM) characterised by glycogen accumulation in the liver leading to hepatomegaly. Mauriac syndrome is considered to be a very rare and preventable complication due to better treatment options for T1DM. Most cases of Mauriac syndrome today involve children and adolescents who face socioeconomic inequities that prevent them from accessing adequate healthcare and affording insulin, as is the case with this patient. The combination of low health literacy, insulin unaffordability, and difficulty accessing healthcare for her chronic condition all contributed to her poorly controlled T1DM. It has been well established that insulin has become difficult to afford for insulin-dependent patients. An alarming one out of four insulin-dependent patients have rationed their doses due to the high cost of insulin. Progress has been made to cap the price of insulin at 35 USD to prevent price-gouging for certain populations in the USA but not all. Young patients with poorly controlled T1DM and low socioeconomic status require higher levels of social support and public health intervention to prevent serious complications of T1DM such as Mauriac syndrome.
- 22 August 2024
- Published by European Medical Group in EMJ Diabetes
- Vol. 12 (1)
Open AccessA Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action
Presented here is a case of Mauriac syndrome with persistent lactatemia in a 21-year-old female with a history of poor glycaemic control. Mauriac syndrome is a severe complication of Type 1 diabetes mellitus (T1DM) characterised by glycogen accumulation in the liver leading to hepatomegaly. Mauriac syndrome is considered to be a very rare and preventable complication due to better treatment options for T1DM. Most cases of Mauriac syndrome today involve children and adolescents who face socioeconomic inequities that prevent them from accessing adequate healthcare and affording insulin, as is the case with this patient. The combination of low health literacy, insulin unaffordability, and difficulty accessing healthcare for her chronic condition all contributed to her poorly controlled T1DM. It has been well established that insulin has become difficult to afford for insulin-dependent patients. An alarming one out of four insulin-dependent patients have rationed their doses due to the high cost of insulin. Progress has been made to cap the price of insulin at 35 USD to prevent price-gouging for certain populations in the USA but not all. Young patients with poorly controlled T1DM and low socioeconomic status require higher levels of social support and public health intervention to prevent serious complications of T1DM such as Mauriac syndrome.
- Open Access
- 30 April 2024
- Published by MDPI AG in Journal of Mind and Medical Sciences
- Vol. 11 (1) , 4-9
Open versus Laparoscopic Appendectomy: A Literature Review
Appendectomy is the most common emergency abdominal surgery in the United States. Open appendectomy has been the standard procedure for decades, whereas laparoscopic appendectomy is a newer, less-invasive method of removing the appendix. This review intends to elucidate the similarities and differences between these two procedures as well as explore the advantages and disadvantages of each approach. Socioeconomic factors, associated costs, preoperative imaging, operative time and methods, length of hospital stay, recovery time, and complications associated with open and laparoscopic appendectomy are discussed. Overall, laparoscopic appendectomy has shorter hospital stays and recovery times, requires less analgesics, and results in better postoperative outcomes. Although such an analysis/comparison involves several perspectives, a review of the available literature suggests that laparoscopic appendectomy is the operation of choice in most cases.
- 30 April 2024
- Published by MDPI AG in Journal of Mind and Medical Sciences
- Vol. 11 (1) , 4-9
Open AccessOpen versus Laparoscopic Appendectomy: A Literature Review
Appendectomy is the most common emergency abdominal surgery in the United States. Open appendectomy has been the standard procedure for decades, whereas laparoscopic appendectomy is a newer, less-invasive method of removing the appendix. This review intends to elucidate the similarities and differences between these two procedures as well as explore the advantages and disadvantages of each approach. Socioeconomic factors, associated costs, preoperative imaging, operative time and methods, length of hospital stay, recovery time, and complications associated with open and laparoscopic appendectomy are discussed. Overall, laparoscopic appendectomy has shorter hospital stays and recovery times, requires less analgesics, and results in better postoperative outcomes. Although such an analysis/comparison involves several perspectives, a review of the available literature suggests that laparoscopic appendectomy is the operation of choice in most cases.
- Open Access
- 9 April 2024
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 17 (1) , 1-6
Rapid versus gradual external ventricular drain weaning: a general review of best practices
Rapid versus gradual external ventricular drain (EVD) weaning methods have been widely debated, aiming to establish a standard clinical practice. The techniques used in each approach offer their own set of benefits and associated risks. Many published works continue to deliberate and dispute each other on the topic, as many believe gradual weaning is preferable due to its perceived potential to decrease ventriculoperitoneal shunt (VPS) dependency. In contrast, rapid weaning is known to have benefits such as a reduction in ventriculostomy-associated infections. Additionally, both weaning methods have been further debated due to the perception of the risks associated, which for gradual weaning includes a longer hospital stay. This literature review explores both sides of this debate, providing pros and cons to each weaning method to better unify the disconnect within the field. Based on the current research available, it is clear that due to a lengthy and more consistent list of benefits as well as overall decreased associated risks, rapid weaning is the superior form of EVD treatment method and should become the standard for clinical practice when performing EVDs on patients suffering from aneurysmal subarachnoid hemorrhages.
- 9 April 2024
- Published by Korean Neurocritical Care Society in Journal of Neurocritical Care
- Vol. 17 (1) , 1-6
Open AccessRapid versus gradual external ventricular drain weaning: a general review of best practices
Rapid versus gradual external ventricular drain (EVD) weaning methods have been widely debated, aiming to establish a standard clinical practice. The techniques used in each approach offer their own set of benefits and associated risks. Many published works continue to deliberate and dispute each other on the topic, as many believe gradual weaning is preferable due to its perceived potential to decrease ventriculoperitoneal shunt (VPS) dependency. In contrast, rapid weaning is known to have benefits such as a reduction in ventriculostomy-associated infections. Additionally, both weaning methods have been further debated due to the perception of the risks associated, which for gradual weaning includes a longer hospital stay. This literature review explores both sides of this debate, providing pros and cons to each weaning method to better unify the disconnect within the field. Based on the current research available, it is clear that due to a lengthy and more consistent list of benefits as well as overall decreased associated risks, rapid weaning is the superior form of EVD treatment method and should become the standard for clinical practice when performing EVDs on patients suffering from aneurysmal subarachnoid hemorrhages.